ARCHIVES

Clinical Trials Approved By NCI During November Are Listed

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Program A “Noble Venture,” Kennedy Says; $937 Million Not Enough, Upton Says

April 13, 1979

Cancer Letter Takes Two Weeks Off

August 28, 1987

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

NCI Advisory Group, Other Cancer Meetings

August 30, 1991

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990